Supreme Court Order Allows Abortion Drugs by Mail to Flow as Case Continues

The U.S. Supreme Court recently granted a stay of a Fifth Circuit order suspending the illegal regulatory changes by the Food and Drug Administration (FDA) that eliminated the requirements for patients to obtain the abortion-inducing drug mifepristone in person from a qualified medical provider. For two decades, the FDA required in-person dispensing of Mifepristone, but […]